EKF Diagnostics Holdings Plc (EKF) - Total Liabilities
Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has total liabilities worth GBX10.86 Million GBX (≈ $1.32K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
EKF Diagnostics Holdings Plc - Total Liabilities Trend (2001–2025)
This chart illustrates how EKF Diagnostics Holdings Plc's total liabilities have evolved over time, based on quarterly financial data. See EKF Diagnostics Holdings Plc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
EKF Diagnostics Holdings Plc Competitors by Total Liabilities
The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Smartfren Telecom Tbk
JK:FREN
|
Indonesia | Rp21.74 Trillion |
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
USA | $608.34 Million |
|
Fuse Cobalt Inc
V:FUSE
|
Canada | CA$166.95K |
|
Niraj Ispat Industries Limited
NSE:NIRAJISPAT
|
India | Rs54.63 Million |
|
GCP Asset Backed Income Fund Limited
LSE:GABI
|
UK | GBX590.00K |
|
Aptitude Software Group PLC
LSE:APTD
|
UK | GBX47.95 Million |
|
GlucoTrack Inc
NASDAQ:GCTK
|
USA | $5.01 Million |
|
Polledo S.A.
BA:POLL
|
Argentina | AR$427.53 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down EKF Diagnostics Holdings Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of EKF Diagnostics Holdings Plc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EKF Diagnostics Holdings Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EKF Diagnostics Holdings Plc (2001–2025)
The table below shows the annual total liabilities of EKF Diagnostics Holdings Plc from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX10.86 Million ≈ $1.32K |
+27.29% |
| 2024-12-31 | GBX8.53 Million ≈ $1.04K |
-32.45% |
| 2023-12-31 | GBX12.63 Million ≈ $1.54K |
-14.46% |
| 2022-12-31 | GBX14.77 Million ≈ $1.80K |
-27.53% |
| 2021-12-31 | GBX20.38 Million ≈ $2.48K |
-11.65% |
| 2020-12-31 | GBX23.07 Million ≈ $2.81K |
+44.57% |
| 2019-12-31 | GBX15.95 Million ≈ $1.94K |
-8.71% |
| 2018-12-31 | GBX17.48 Million ≈ $2.13K |
+4.90% |
| 2017-12-31 | GBX16.66 Million ≈ $2.03K |
-22.38% |
| 2016-12-31 | GBX21.46 Million ≈ $2.61K |
-14.62% |
| 2015-12-31 | GBX25.14 Million ≈ $3.06K |
-48.07% |
| 2014-12-31 | GBX48.40 Million ≈ $5.89K |
+144.45% |
| 2013-12-31 | GBX19.80 Million ≈ $2.41K |
+21.55% |
| 2012-12-31 | GBX16.29 Million ≈ $1.98K |
-23.54% |
| 2011-12-31 | GBX21.31 Million ≈ $2.59K |
+71.13% |
| 2010-12-31 | GBX12.45 Million ≈ $1.51K |
+1502.32% |
| 2009-12-31 | GBX777.00K ≈ $94.54 |
+16.32% |
| 2008-12-31 | GBX668.00K ≈ $81.28 |
+13.41% |
| 2007-12-31 | GBX589.00K ≈ $71.66 |
-31.67% |
| 2006-12-31 | GBX862.00K ≈ $104.88 |
-23.65% |
| 2005-12-31 | GBX1.13 Million ≈ $137.37 |
-68.13% |
| 2004-12-31 | GBX3.54 Million ≈ $430.96 |
-8.43% |
| 2003-12-31 | GBX3.87 Million ≈ $470.62 |
+7.86% |
| 2003-06-30 | GBX3.59 Million ≈ $436.31 |
+1.59% |
| 2002-12-31 | GBX3.53 Million ≈ $429.50 |
-32.56% |
| 2001-12-31 | GBX5.23 Million ≈ $636.83 |
-- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more